nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—hepatitis B	0.636	1	CbGaD
Enzalutamide—Fracture—Adefovir Dipivoxil—hepatitis B	0.0125	0.0507	CcSEcCtD
Enzalutamide—Multiple fractures—Adefovir Dipivoxil—hepatitis B	0.0125	0.0507	CcSEcCtD
Enzalutamide—AR—semen—hepatitis B	0.0104	0.217	CbGeAlD
Enzalutamide—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.00682	0.0277	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Telbivudine—hepatitis B	0.00619	0.0251	CcSEcCtD
Enzalutamide—Sepsis—Telbivudine—hepatitis B	0.00531	0.0215	CcSEcCtD
Enzalutamide—Neutropenia—Entecavir—hepatitis B	0.00437	0.0177	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Entecavir—hepatitis B	0.00434	0.0176	CcSEcCtD
Enzalutamide—Haematuria—Entecavir—hepatitis B	0.00397	0.0161	CcSEcCtD
Enzalutamide—Nasopharyngitis—Telbivudine—hepatitis B	0.00397	0.0161	CcSEcCtD
Enzalutamide—Muscular weakness—Telbivudine—hepatitis B	0.00392	0.0159	CcSEcCtD
Enzalutamide—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00388	0.0157	CcSEcCtD
Enzalutamide—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00381	0.0155	CcSEcCtD
Enzalutamide—Oedema peripheral—Entecavir—hepatitis B	0.00368	0.0149	CcSEcCtD
Enzalutamide—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00362	0.0147	CcSEcCtD
Enzalutamide—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0036	0.0146	CcSEcCtD
Enzalutamide—Neutropenia—Telbivudine—hepatitis B	0.00359	0.0146	CcSEcCtD
Enzalutamide—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00359	0.0145	CcSEcCtD
Enzalutamide—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00358	0.0145	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00357	0.0145	CcSEcCtD
Enzalutamide—CYP2C19—blood plasma—hepatitis B	0.00352	0.0734	CbGeAlD
Enzalutamide—Musculoskeletal pain—Lamivudine—hepatitis B	0.00349	0.0142	CcSEcCtD
Enzalutamide—Mental disorder—Entecavir—hepatitis B	0.00328	0.0133	CcSEcCtD
Enzalutamide—Back pain—Adefovir Dipivoxil—hepatitis B	0.00307	0.0125	CcSEcCtD
Enzalutamide—CYP2C8—blood plasma—hepatitis B	0.00307	0.0641	CbGeAlD
Enzalutamide—Hypoaesthesia—Telbivudine—hepatitis B	0.00306	0.0124	CcSEcCtD
Enzalutamide—Pharyngitis—Telbivudine—hepatitis B	0.00305	0.0124	CcSEcCtD
Enzalutamide—Connective tissue disorder—Telbivudine—hepatitis B	0.00302	0.0122	CcSEcCtD
Enzalutamide—Sepsis—Lamivudine—hepatitis B	0.00299	0.0121	CcSEcCtD
Enzalutamide—Leukopenia—Entecavir—hepatitis B	0.00291	0.0118	CcSEcCtD
Enzalutamide—CYP3A5—blood plasma—hepatitis B	0.00277	0.0578	CbGeAlD
Enzalutamide—CYP2B6—blood plasma—hepatitis B	0.00275	0.0575	CbGeAlD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00275	0.0112	CcSEcCtD
Enzalutamide—CYP2C9—blood plasma—hepatitis B	0.00273	0.0569	CbGeAlD
Enzalutamide—Injury—Lamivudine—hepatitis B	0.00272	0.011	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00269	0.0109	CcSEcCtD
Enzalutamide—Infection—Entecavir—hepatitis B	0.00264	0.0107	CcSEcCtD
Enzalutamide—Nervous system disorder—Entecavir—hepatitis B	0.00261	0.0106	CcSEcCtD
Enzalutamide—Back pain—Telbivudine—hepatitis B	0.00259	0.0105	CcSEcCtD
Enzalutamide—Skin disorder—Entecavir—hepatitis B	0.00258	0.0105	CcSEcCtD
Enzalutamide—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00254	0.0103	CcSEcCtD
Enzalutamide—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00254	0.0103	CcSEcCtD
Enzalutamide—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00252	0.0102	CcSEcCtD
Enzalutamide—Insomnia—Entecavir—hepatitis B	0.0024	0.00975	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00236	0.00958	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Entecavir—hepatitis B	0.00229	0.0093	CcSEcCtD
Enzalutamide—Fatigue—Entecavir—hepatitis B	0.00229	0.00929	CcSEcCtD
Enzalutamide—Arthralgia—Telbivudine—hepatitis B	0.00228	0.00923	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00226	0.00917	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00224	0.00908	CcSEcCtD
Enzalutamide—Nasopharyngitis—Lamivudine—hepatitis B	0.00224	0.00908	CcSEcCtD
Enzalutamide—Muscular weakness—Lamivudine—hepatitis B	0.00221	0.00895	CcSEcCtD
Enzalutamide—Nervous system disorder—Telbivudine—hepatitis B	0.00214	0.00868	CcSEcCtD
Enzalutamide—Thrombocytopenia—Telbivudine—hepatitis B	0.00214	0.00867	CcSEcCtD
Enzalutamide—Skin disorder—Telbivudine—hepatitis B	0.00212	0.0086	CcSEcCtD
Enzalutamide—Bronchitis—Lamivudine—hepatitis B	0.00208	0.00844	CcSEcCtD
Enzalutamide—CYP3A4—blood plasma—hepatitis B	0.00208	0.0434	CbGeAlD
Enzalutamide—CYP2D6—blood plasma—hepatitis B	0.00205	0.0427	CbGeAlD
Enzalutamide—Neutropenia—Lamivudine—hepatitis B	0.00202	0.0082	CcSEcCtD
Enzalutamide—Pollakiuria—Lamivudine—hepatitis B	0.002	0.0081	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00199	0.00806	CcSEcCtD
Enzalutamide—Insomnia—Telbivudine—hepatitis B	0.00197	0.00801	CcSEcCtD
Enzalutamide—Paraesthesia—Telbivudine—hepatitis B	0.00196	0.00795	CcSEcCtD
Enzalutamide—Asthenia—Entecavir—hepatitis B	0.00191	0.00773	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00188	0.00764	CcSEcCtD
Enzalutamide—Fatigue—Telbivudine—hepatitis B	0.00188	0.00763	CcSEcCtD
Enzalutamide—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00186	0.00754	CcSEcCtD
Enzalutamide—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00183	0.00744	CcSEcCtD
Enzalutamide—Epistaxis—Lamivudine—hepatitis B	0.00182	0.00738	CcSEcCtD
Enzalutamide—Diarrhoea—Entecavir—hepatitis B	0.00182	0.00737	CcSEcCtD
Enzalutamide—Sinusitis—Lamivudine—hepatitis B	0.00181	0.00734	CcSEcCtD
Enzalutamide—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00177	0.00719	CcSEcCtD
Enzalutamide—Dizziness—Entecavir—hepatitis B	0.00176	0.00713	CcSEcCtD
Enzalutamide—Rhinitis—Lamivudine—hepatitis B	0.00174	0.00704	CcSEcCtD
Enzalutamide—Hypoaesthesia—Lamivudine—hepatitis B	0.00172	0.00699	CcSEcCtD
Enzalutamide—Pharyngitis—Lamivudine—hepatitis B	0.00172	0.00697	CcSEcCtD
Enzalutamide—Connective tissue disorder—Lamivudine—hepatitis B	0.0017	0.0069	CcSEcCtD
Enzalutamide—Headache—Entecavir—hepatitis B	0.00166	0.00675	CcSEcCtD
Enzalutamide—Headache—Adefovir Dipivoxil—hepatitis B	0.00162	0.00659	CcSEcCtD
Enzalutamide—Asthenia—Telbivudine—hepatitis B	0.00157	0.00635	CcSEcCtD
Enzalutamide—Pruritus—Telbivudine—hepatitis B	0.00154	0.00626	CcSEcCtD
Enzalutamide—Diarrhoea—Telbivudine—hepatitis B	0.00149	0.00606	CcSEcCtD
Enzalutamide—ABCB1—blood plasma—hepatitis B	0.00147	0.0307	CbGeAlD
Enzalutamide—Back pain—Lamivudine—hepatitis B	0.00146	0.00591	CcSEcCtD
Enzalutamide—Dizziness—Telbivudine—hepatitis B	0.00144	0.00585	CcSEcCtD
Enzalutamide—AR—blood—hepatitis B	0.00139	0.029	CbGeAlD
Enzalutamide—Headache—Telbivudine—hepatitis B	0.00137	0.00555	CcSEcCtD
Enzalutamide—Vertigo—Lamivudine—hepatitis B	0.00135	0.00549	CcSEcCtD
Enzalutamide—Leukopenia—Lamivudine—hepatitis B	0.00135	0.00547	CcSEcCtD
Enzalutamide—Convulsion—Lamivudine—hepatitis B	0.00131	0.0053	CcSEcCtD
Enzalutamide—CYP2C19—blood—hepatitis B	0.00129	0.0269	CbGeAlD
Enzalutamide—Arthralgia—Lamivudine—hepatitis B	0.00128	0.0052	CcSEcCtD
Enzalutamide—Anxiety—Lamivudine—hepatitis B	0.00128	0.00519	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00127	0.00517	CcSEcCtD
Enzalutamide—ALB—liver—hepatitis B	0.00125	0.0261	CbGeAlD
Enzalutamide—Infection—Lamivudine—hepatitis B	0.00122	0.00496	CcSEcCtD
Enzalutamide—Nervous system disorder—Lamivudine—hepatitis B	0.00121	0.00489	CcSEcCtD
Enzalutamide—Thrombocytopenia—Lamivudine—hepatitis B	0.0012	0.00488	CcSEcCtD
Enzalutamide—Skin disorder—Lamivudine—hepatitis B	0.00119	0.00485	CcSEcCtD
Enzalutamide—CYP2C8—blood—hepatitis B	0.00112	0.0235	CbGeAlD
Enzalutamide—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00112	0.00454	CcSEcCtD
Enzalutamide—Insomnia—Lamivudine—hepatitis B	0.00111	0.00451	CcSEcCtD
Enzalutamide—Paraesthesia—Lamivudine—hepatitis B	0.0011	0.00448	CcSEcCtD
Enzalutamide—AR—liver—hepatitis B	0.00109	0.0227	CbGeAlD
Enzalutamide—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00106	0.00431	CcSEcCtD
Enzalutamide—Fatigue—Lamivudine—hepatitis B	0.00106	0.0043	CcSEcCtD
Enzalutamide—CYP3A5—blood—hepatitis B	0.00101	0.0212	CbGeAlD
Enzalutamide—CYP2B6—blood—hepatitis B	0.00101	0.021	CbGeAlD
Enzalutamide—CYP2C19—liver—hepatitis B	0.00101	0.021	CbGeAlD
Enzalutamide—CYP2C9—blood—hepatitis B	0.000999	0.0208	CbGeAlD
Enzalutamide—Asthenia—Lamivudine—hepatitis B	0.000883	0.00358	CcSEcCtD
Enzalutamide—CYP2C8—liver—hepatitis B	0.000879	0.0184	CbGeAlD
Enzalutamide—Pruritus—Lamivudine—hepatitis B	0.00087	0.00353	CcSEcCtD
Enzalutamide—Diarrhoea—Lamivudine—hepatitis B	0.000842	0.00341	CcSEcCtD
Enzalutamide—Dizziness—Lamivudine—hepatitis B	0.000813	0.0033	CcSEcCtD
Enzalutamide—CYP3A5—liver—hepatitis B	0.000794	0.0166	CbGeAlD
Enzalutamide—CYP2B6—liver—hepatitis B	0.000789	0.0165	CbGeAlD
Enzalutamide—CYP2C9—liver—hepatitis B	0.000781	0.0163	CbGeAlD
Enzalutamide—Headache—Lamivudine—hepatitis B	0.000771	0.00312	CcSEcCtD
Enzalutamide—CYP3A4—blood—hepatitis B	0.000762	0.0159	CbGeAlD
Enzalutamide—CYP2D6—blood—hepatitis B	0.000749	0.0156	CbGeAlD
Enzalutamide—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000734	0.0106	CbGpPWpGaD
Enzalutamide—CYP2D6—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000731	0.0105	CbGpPWpGaD
Enzalutamide—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000725	0.0104	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.000688	0.00989	CbGpPWpGaD
Enzalutamide—CYP3A4—liver—hepatitis B	0.000596	0.0124	CbGeAlD
Enzalutamide—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.000594	0.00854	CbGpPWpGaD
Enzalutamide—CYP2D6—liver—hepatitis B	0.000586	0.0122	CbGeAlD
Enzalutamide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000567	0.00816	CbGpPWpGaD
Enzalutamide—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000554	0.00796	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.000539	0.00776	CbGpPWpGaD
Enzalutamide—ABCB1—blood—hepatitis B	0.000539	0.0113	CbGeAlD
Enzalutamide—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—hepatitis B	0.000521	0.00749	CbGpPWpGaD
Enzalutamide—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000517	0.00744	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.000512	0.00736	CbGpPWpGaD
Enzalutamide—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000497	0.00715	CbGpPWpGaD
Enzalutamide—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000478	0.00687	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—GGT2—hepatitis B	0.000464	0.00668	CbGpPWpGaD
Enzalutamide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000454	0.00653	CbGpPWpGaD
Enzalutamide—CYP2B6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000448	0.00644	CbGpPWpGaD
Enzalutamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000444	0.00638	CbGpPWpGaD
Enzalutamide—CYP3A5—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000438	0.0063	CbGpPWpGaD
Enzalutamide—ABCB1—liver—hepatitis B	0.000422	0.0088	CbGeAlD
Enzalutamide—AR—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.000417	0.00599	CbGpPWpGaD
Enzalutamide—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000404	0.00581	CbGpPWpGaD
Enzalutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000384	0.00553	CbGpPWpGaD
Enzalutamide—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000379	0.00546	CbGpPWpGaD
Enzalutamide—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000368	0.00529	CbGpPWpGaD
Enzalutamide—AR—Notch-mediated HES/HEY network—CD4—hepatitis B	0.000366	0.00526	CbGpPWpGaD
Enzalutamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00036	0.00517	CbGpPWpGaD
Enzalutamide—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.000347	0.00499	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000346	0.00498	CbGpPWpGaD
Enzalutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000343	0.00493	CbGpPWpGaD
Enzalutamide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000341	0.00491	CbGpPWpGaD
Enzalutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000339	0.00487	CbGpPWpGaD
Enzalutamide—CYP2B6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000332	0.00477	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.00033	0.00475	CbGpPWpGaD
Enzalutamide—CYP3A5—Metapathway biotransformation—AKR1B1—hepatitis B	0.000325	0.00467	CbGpPWpGaD
Enzalutamide—CYP2B6—Biological oxidations—GGT2—hepatitis B	0.000323	0.00464	CbGpPWpGaD
Enzalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000316	0.00454	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—GGT2—hepatitis B	0.000315	0.00454	CbGpPWpGaD
Enzalutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—hepatitis B	0.000315	0.00453	CbGpPWpGaD
Enzalutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000313	0.0045	CbGpPWpGaD
Enzalutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000312	0.00448	CbGpPWpGaD
Enzalutamide—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000311	0.00448	CbGpPWpGaD
Enzalutamide—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.00031	0.00446	CbGpPWpGaD
Enzalutamide—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000309	0.00444	CbGpPWpGaD
Enzalutamide—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000283	0.00406	CbGpPWpGaD
Enzalutamide—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.000281	0.00404	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—HSPA5—hepatitis B	0.000281	0.00404	CbGpPWpGaD
Enzalutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000278	0.004	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.000273	0.00393	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—hepatitis B	0.000268	0.00385	CbGpPWpGaD
Enzalutamide—AR—Coregulation of Androgen receptor activity—CTNNB1—hepatitis B	0.000264	0.00379	CbGpPWpGaD
Enzalutamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000256	0.00368	CbGpPWpGaD
Enzalutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000254	0.00365	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—hepatitis B	0.000254	0.00365	CbGpPWpGaD
Enzalutamide—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000251	0.00361	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—NR0B2—hepatitis B	0.000248	0.00357	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000247	0.00355	CbGpPWpGaD
Enzalutamide—ALB—FOXA2 and FOXA3 transcription factor networks—F2—hepatitis B	0.000245	0.00352	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000244	0.00351	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000235	0.00338	CbGpPWpGaD
Enzalutamide—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000231	0.00332	CbGpPWpGaD
Enzalutamide—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000229	0.00329	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000224	0.00323	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000222	0.0032	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—GGT1—hepatitis B	0.00022	0.00316	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—F2—hepatitis B	0.000218	0.00313	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—hepatitis B	0.000212	0.00305	CbGpPWpGaD
Enzalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000206	0.00297	CbGpPWpGaD
Enzalutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000205	0.00295	CbGpPWpGaD
Enzalutamide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000204	0.00293	CbGpPWpGaD
Enzalutamide—CYP2B6—Biological oxidations—CYP2A6—hepatitis B	0.000196	0.00281	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000195	0.0028	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—CTNNB1—hepatitis B	0.000195	0.0028	CbGpPWpGaD
Enzalutamide—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000194	0.00278	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—CYP2A6—hepatitis B	0.000191	0.00275	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—CDKN1A—hepatitis B	0.00019	0.00274	CbGpPWpGaD
Enzalutamide—AR—Androgen receptor signaling pathway—PTEN—hepatitis B	0.00019	0.00273	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000188	0.0027	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HBE1—hepatitis B	0.000186	0.00267	CbGpPWpGaD
Enzalutamide—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000178	0.00256	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—F2—hepatitis B	0.000177	0.00255	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000173	0.00249	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000173	0.00249	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—HNF4A—hepatitis B	0.000172	0.00247	CbGpPWpGaD
Enzalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000167	0.00241	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000166	0.00238	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—IFNG—hepatitis B	0.000165	0.00237	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000161	0.00232	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000155	0.00223	CbGpPWpGaD
Enzalutamide—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000153	0.0022	CbGpPWpGaD
Enzalutamide—CYP2B6—Biological oxidations—GGT1—hepatitis B	0.000153	0.0022	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000153	0.00219	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000151	0.00217	CbGpPWpGaD
Enzalutamide—CYP3A5—Biological oxidations—GGT1—hepatitis B	0.000149	0.00215	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000148	0.00212	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000147	0.00211	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000141	0.00203	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—F2—hepatitis B	0.000141	0.00202	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000139	0.00201	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—NFKB1—hepatitis B	0.000137	0.00197	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000136	0.00195	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000135	0.00194	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IFNG—hepatitis B	0.000134	0.00193	CbGpPWpGaD
Enzalutamide—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000129	0.00186	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000128	0.00184	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	0.000125	0.00179	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000124	0.00179	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000124	0.00179	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000124	0.00178	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000121	0.00173	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—NR0B2—hepatitis B	0.000119	0.00172	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL2—hepatitis B	0.000119	0.00171	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000115	0.00166	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—NFKB1—hepatitis B	0.000112	0.00161	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000109	0.00157	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000109	0.00156	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—TNF—hepatitis B	0.000107	0.00154	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—IFNG—hepatitis B	0.000107	0.00153	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000106	0.00153	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000106	0.00152	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000105	0.00151	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000103	0.00149	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000103	0.00148	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000103	0.00148	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.000102	0.00146	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	9.77e-05	0.0014	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—TNF—hepatitis B	9.38e-05	0.00135	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—IL2—hepatitis B	9.05e-05	0.0013	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	8.91e-05	0.00128	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	8.89e-05	0.00128	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—NFKB1—hepatitis B	8.87e-05	0.00128	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TNF—hepatitis B	8.69e-05	0.00125	CbGpPWpGaD
Enzalutamide—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	8.62e-05	0.00124	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	8.55e-05	0.00123	CbGpPWpGaD
Enzalutamide—AR—Integrated Breast Cancer Pathway—TP53—hepatitis B	8.49e-05	0.00122	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—HNF4A—hepatitis B	8.28e-05	0.00119	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	7.98e-05	0.00115	CbGpPWpGaD
Enzalutamide—ALB—Platelet degranulation—TGFB1—hepatitis B	7.98e-05	0.00115	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	7.95e-05	0.00114	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	7.66e-05	0.0011	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—TP53—hepatitis B	7.66e-05	0.0011	CbGpPWpGaD
Enzalutamide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	7.6e-05	0.00109	CbGpPWpGaD
Enzalutamide—AR—SIDS Susceptibility Pathways—IL6—hepatitis B	7.57e-05	0.00109	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TGFB1—hepatitis B	7.06e-05	0.00102	CbGpPWpGaD
Enzalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	7.04e-05	0.00101	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL6—hepatitis B	7.01e-05	0.00101	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—GGT1—hepatitis B	6.94e-05	0.000997	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—TNF—hepatitis B	6.9e-05	0.000992	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	6.74e-05	0.000968	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TNF—hepatitis B	6.59e-05	0.000948	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HSPA5—hepatitis B	6.42e-05	0.000924	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IFNB1—hepatitis B	5.8e-05	0.000833	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKR1B1—hepatitis B	5.76e-05	0.000828	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IFNA1—hepatitis B	5.65e-05	0.000813	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKR1B1—hepatitis B	5.63e-05	0.000809	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—IL6—hepatitis B	5.57e-05	0.000801	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GGT2—hepatitis B	5.52e-05	0.000794	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GGT2—hepatitis B	5.4e-05	0.000776	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IFNA2—hepatitis B	5.26e-05	0.000757	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.96e-05	0.000714	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.93e-05	0.00071	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKR1B1—hepatitis B	4.87e-05	0.000701	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKR1B1—hepatitis B	4.85e-05	0.000697	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GGT2—hepatitis B	4.67e-05	0.000672	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GGT2—hepatitis B	4.65e-05	0.000668	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	4.54e-05	0.000652	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.43e-05	0.000637	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKR1B1—hepatitis B	4.35e-05	0.000626	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	4.31e-05	0.00062	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKR1B1—hepatitis B	4.25e-05	0.000611	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	4.21e-05	0.000606	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	4.2e-05	0.000604	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	4.18e-05	0.000601	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GGT2—hepatitis B	4.17e-05	0.0006	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GGT2—hepatitis B	4.07e-05	0.000585	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.04e-05	0.000581	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKR1B1—hepatitis B	4e-05	0.000575	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKR1B1—hepatitis B	3.97e-05	0.00057	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GGT2—hepatitis B	3.84e-05	0.000552	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GGT2—hepatitis B	3.8e-05	0.000547	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	3.54e-05	0.000509	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	3.48e-05	0.000501	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—F2—hepatitis B	3.47e-05	0.000499	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NOS2—hepatitis B	3.43e-05	0.000493	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP2A6—hepatitis B	3.34e-05	0.000481	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP2A6—hepatitis B	3.27e-05	0.00047	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	3.25e-05	0.000468	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GOT2—hepatitis B	3.02e-05	0.000435	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GOT2—hepatitis B	2.96e-05	0.000425	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.87e-05	0.000412	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP2A6—hepatitis B	2.83e-05	0.000407	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP2A6—hepatitis B	2.82e-05	0.000405	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.64e-05	0.00038	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.62e-05	0.000376	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GOT1—hepatitis B	2.61e-05	0.000375	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GGT1—hepatitis B	2.61e-05	0.000375	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GOT2—hepatitis B	2.56e-05	0.000368	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GGT1—hepatitis B	2.55e-05	0.000367	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GOT1—hepatitis B	2.55e-05	0.000367	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GOT2—hepatitis B	2.55e-05	0.000366	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP2A6—hepatitis B	2.53e-05	0.000363	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GGT2—hepatitis B	2.51e-05	0.000361	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP2A6—hepatitis B	2.47e-05	0.000355	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.36e-05	0.000339	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IL2—hepatitis B	2.34e-05	0.000336	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP2A6—hepatitis B	2.32e-05	0.000334	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP2A6—hepatitis B	2.3e-05	0.000331	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GOT2—hepatitis B	2.29e-05	0.000329	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GOT2—hepatitis B	2.23e-05	0.000321	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GOT1—hepatitis B	2.21e-05	0.000318	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GGT1—hepatitis B	2.21e-05	0.000318	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GGT1—hepatitis B	2.2e-05	0.000316	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GOT1—hepatitis B	2.2e-05	0.000316	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	2.19e-05	0.000314	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.15e-05	0.000309	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GOT2—hepatitis B	2.1e-05	0.000302	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GOT2—hepatitis B	2.08e-05	0.0003	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.01e-05	0.00029	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2e-05	0.000288	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GGT1—hepatitis B	1.97e-05	0.000284	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GOT1—hepatitis B	1.97e-05	0.000284	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GGT1—hepatitis B	1.93e-05	0.000277	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GOT1—hepatitis B	1.93e-05	0.000277	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—hepatitis B	1.82e-05	0.000262	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GGT1—hepatitis B	1.81e-05	0.000261	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GOT1—hepatitis B	1.81e-05	0.000261	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GOT1—hepatitis B	1.8e-05	0.000259	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GGT1—hepatitis B	1.8e-05	0.000259	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.8e-05	0.000259	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.64e-05	0.000236	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.52e-05	0.000219	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—hepatitis B	1.5e-05	0.000216	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—hepatitis B	1.39e-05	0.0002	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GOT2—hepatitis B	1.37e-05	0.000198	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—hepatitis B	1.36e-05	0.000195	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GOT1—hepatitis B	1.19e-05	0.000171	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GGT1—hepatitis B	1.19e-05	0.000171	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—hepatitis B	1.18e-05	0.000169	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTEN—hepatitis B	1.06e-05	0.000152	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—hepatitis B	1.05e-05	0.000151	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTEN—hepatitis B	1.04e-05	0.000149	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—hepatitis B	1.02e-05	0.000147	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—hepatitis B	9.65e-06	0.000139	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—hepatitis B	9.57e-06	0.000138	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTEN—hepatitis B	8.97e-06	0.000129	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTEN—hepatitis B	8.92e-06	0.000128	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTEN—hepatitis B	8.01e-06	0.000115	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTEN—hepatitis B	7.81e-06	0.000112	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTEN—hepatitis B	7.36e-06	0.000106	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTEN—hepatitis B	7.3e-06	0.000105	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—hepatitis B	6.31e-06	9.07e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTEN—hepatitis B	4.81e-06	6.92e-05	CbGpPWpGaD
